About Us  |   Contact Us  |   Register  | Login  |   

Follow HedgeWorld on Twitter HedgeWorld on LinkedIn






HEDGEWORLD NEWS
Search the News
Advanced News Search
HedgeWorld News by Region
United States / Americas
Europe
Asia / Australia
International
HedgeWorld News Sections
Managed Futures & Derivatives
Daily News
Regulatory/Legal
Strategies/Analysis
Technology
Opinion
People
Indexes
Other News Features
Most Popular
LexisNexis Headlines
Reuters Headlines
The HedgeWorld Blog
Alternative Advantage Daily Newsletter
RSS Service
Sign Up For Email News Alerts
Reprints



CVS Caremark set to pay $20 mln to resolve SEC investigation
08/02/2013 Email this story  |  Printable Version

Aug 2 (Reuters) - CVS Caremark Corp said on Friday that it plans to pay a $20 million civil penalty to resolve a U.S. Securities and Exchange Commission investigation into 2009 comments and staff securities transactions and its accounting for an acquisition.

The drugstore and pharmacy benefits management company said the settlement will be entered on a "no admit or deny" basis, resolving a number of alleged violations of the Securities Act of 1933 and the Securities Exchange Act of 1934, including some anti-fraud provisions.

CVS received a subpoena from the SEC in February 2011, followed by additional subpoenas and other requests for information related to issues such as public disclosures the company made in 2009, securities transactions by some company officers and employees during that year, and the purchase accounting for its 2008 acquisition of Longs Drug Stores Corp.

The settlement, reached in principle with staff of the SEC's Boston regional office, is subject to the completion of final documentation and approval by the SEC and federal court, CVS said. The company said it has fully reserved funds for the settlement and will not need to restate earnings for any period.


Email This Story to a Friend   |   Display Printable Version of This Story

Story Copyright © 1999-2014 Reuters HedgeWorld All rights reserved.

HedgeWorld News is sponsored by:






Lipper    Privacy   User Policy  Legal Disclosure Copyright/DMCA  Site Map    FAQ    Glossary  Thomson Reuters for Hedge Funds
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of HedgeWorld content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. HedgeWorld is a registered trademark of Thomson Reuters.